70
Participants
Start Date
June 30, 2012
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Omega-3 Fatty Acids
"study group, included standard risk ALL pediatric patients who were supplemented with oral omega-3 capsule (one capsule / day) .~Omega-3 was supplied as soft gelatin capsules in a dose of 1000 mg of omega-3 fatty acids/day ."
Methotrexate
control group, included pediatric patients with standard risk acute lymphoblastic leukemia in maintenance phase day 0 and receiving oral Methotrexate (20 mg / m2) weekly without any supplementation .
Nancy Samir Elbarbary
OTHER